Landscape of known and novel myeloid neoplasia fusions identified by a multimodal comprehensive genomic profiling test in 789 patients
Literature
Read More
Single-tube NGS profiling allows identification of molecular signature in ALL patients
Literature
Read More
NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023
Press Release
Read More
NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test
Press Release
Read More
NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP
Press Release
Read More
NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference
Press Release
Read More